Influence of multidisciplinary team care with abundant nurse staffing on patient-reported outcomes among patients with inflammatory bowel disease in clinical remission.


Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
05 Jun 2024
Historique:
received: 26 10 2023
accepted: 25 03 2024
medline: 5 6 2024
pubmed: 5 6 2024
entrez: 4 6 2024
Statut: epublish

Résumé

Patients with inflammatory bowel disease (IBD) experience difficulties in daily life and demanding self-care needs. The goal of our support for patients is to ease their difficulties and improve their belief in their capacity to self-manage their disease (self-efficacy), by increasing their ability for self-care. The nurse's contribution is vital in empowering patients and supporting them to better manage their disease. There is evidence that higher nurse staffing levels are associated with better patient outcomes in acute care settings, but little is known about the outpatient setting. The objective of this study was to explore the impact of multidisciplinary team care with abundant nurse staffing levels on patient-reported outcome measures (PROMs) among patients with IBD, encompassing Crohn's disease (CD) and ulcerative colitis (UC), in clinical remission. Patients with IBD in clinical remission were included because disease activity influences the patient's subjective evaluation. A total of 499 valid responses from two different sources were analyzed: 318 from a specialized IBD clinic with abundant nurse staffing and a multidisciplinary care team (UC: 83, CD: 235) and 181 from an online survey panel (UC: 109, CD: 72). The IBD Self-Efficacy Scale (IBD-SES) and the difficulty of life scale (DLS) were used as disease-specific PROMs. In two multiple regression models adjusted by background characteristics (age, sex, diagnosis [UC/CD], employment status, use of biologics, and disease duration) using the IBD-SES or DLS as a dependent variable, the responses from clinic patients showed a more favorable score (higher self-efficacy or lower difficulty) than the online responses. Multidisciplinary team care with abundant nurse staffing may improve self-efficacy and ease difficulties of life among patients with IBD in clinical remission. These results could help bring attention to nurse staffing in an outpatient setting, which has previously been overlooked, and be the first to provide evidence of its importance in encouraging enhanced staffing levels.

Sections du résumé

BACKGROUND BACKGROUND
Patients with inflammatory bowel disease (IBD) experience difficulties in daily life and demanding self-care needs. The goal of our support for patients is to ease their difficulties and improve their belief in their capacity to self-manage their disease (self-efficacy), by increasing their ability for self-care. The nurse's contribution is vital in empowering patients and supporting them to better manage their disease. There is evidence that higher nurse staffing levels are associated with better patient outcomes in acute care settings, but little is known about the outpatient setting. The objective of this study was to explore the impact of multidisciplinary team care with abundant nurse staffing levels on patient-reported outcome measures (PROMs) among patients with IBD, encompassing Crohn's disease (CD) and ulcerative colitis (UC), in clinical remission.
METHODS METHODS
Patients with IBD in clinical remission were included because disease activity influences the patient's subjective evaluation. A total of 499 valid responses from two different sources were analyzed: 318 from a specialized IBD clinic with abundant nurse staffing and a multidisciplinary care team (UC: 83, CD: 235) and 181 from an online survey panel (UC: 109, CD: 72). The IBD Self-Efficacy Scale (IBD-SES) and the difficulty of life scale (DLS) were used as disease-specific PROMs.
RESULTS RESULTS
In two multiple regression models adjusted by background characteristics (age, sex, diagnosis [UC/CD], employment status, use of biologics, and disease duration) using the IBD-SES or DLS as a dependent variable, the responses from clinic patients showed a more favorable score (higher self-efficacy or lower difficulty) than the online responses.
CONCLUSIONS CONCLUSIONS
Multidisciplinary team care with abundant nurse staffing may improve self-efficacy and ease difficulties of life among patients with IBD in clinical remission. These results could help bring attention to nurse staffing in an outpatient setting, which has previously been overlooked, and be the first to provide evidence of its importance in encouraging enhanced staffing levels.

Identifiants

pubmed: 38835030
doi: 10.1186/s12955-024-02247-w
pii: 10.1186/s12955-024-02247-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Informations de copyright

© 2024. Makoto Tanaka, Aki Kawakami, Kayoko Sakagami, Hiroaki Ito and Takeda Pharmaceutical Company Limited.

Références

Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1–106.
doi: 10.1136/gutjnl-2019-318484 pubmed: 31562236
Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: developing a diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract. 2022;28:923–1049.
doi: 10.1016/j.eprac.2022.08.002 pubmed: 35963508 pmcid: 10200071
van der Veer SN, van Biesen W, Bernaert P, Bolignano D, Brown EA, Covic A, Farrington K, Jager KJ, Kooman J, Macias-Nunez JF, et al. Priority topics for European multidisciplinary guidelines on the management of chronic kidney disease in older adults. Int Urol Nephrol. 2016;48:859–69.
doi: 10.1007/s11255-016-1257-4 pubmed: 26984833
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, Burri H, Butler J, Celutkiene J, Chioncel O, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–726.
doi: 10.1093/eurheartj/ehab368 pubmed: 34447992
AlHabeeb W, Alayoubi F, Hayajneh A, Ullah A, Elshaer F. A strategy to improve adherence to guideline-directed medical therapy (GDMT) and the role of the multidisciplinary team in a heart-failure programme. Cardiovasc J Afr. 2023;34:1–4.
Staudt MD. The Multidisciplinary Team in Pain Management. Neurosurg Clin N Am. 2022;33:241–9.
doi: 10.1016/j.nec.2022.02.002 pubmed: 35718393
Kerr H, Donovan M, McSorley O. Evaluation of the role of the clinical nurse specialist in cancer care: an integrative literature review. Eur J Cancer Care (Engl). 2021;30:e13415.
doi: 10.1111/ecc.13415 pubmed: 33501707
Dall’Ora C, Saville C, Rubbo B, Turner L, Jones J, Griffiths P. Nurse staffing levels and patient outcomes: a systematic review of longitudinal studies. Int J Nurs Stud. 2022;134:104311.
doi: 10.1016/j.ijnurstu.2022.104311 pubmed: 35780608
Griffiths P, Ball J, Drennan J, Dall’Ora C, Jones J, Maruotti A, Pope C, Recio Saucedo A, Simon M. Nurse staffing and patient outcomes: strengths and limitations of the evidence to inform policy and practice. A review and discussion paper based on evidence reviewed for the National Institute for Health and Care Excellence Safe staffing guideline development. Int J Nurs Stud. 2016;63:213–25.
doi: 10.1016/j.ijnurstu.2016.03.012 pubmed: 27130150
Fogg C, Bridges J, Meredith P, Spice C, Field L, Culliford D, Griffiths P. The association between ward staffing levels, mortality and hospital readmission in older hospitalised adults, according to presence of cognitive impairment: a retrospective cohort study. Age Ageing. 2021;50:431–9.
doi: 10.1093/ageing/afaa133 pubmed: 32970798
McHugh MD, Aiken LH, Sloane DM, Windsor C, Douglas C, Yates P. Effects of nurse-to-patient ratio legislation on nurse staffing and patient mortality, readmissions, and length of stay: a prospective study in a panel of hospitals. Lancet. 2021;397:1905–13.
doi: 10.1016/S0140-6736(21)00768-6 pubmed: 33989553 pmcid: 8408834
Kemp K, Dibley L, Chauhan U, Greveson K, Jaghult S, Ashton K, Buckton S, Duncan J, Hartmann P, Ipenburg N, et al. Second N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn’s Disease or Ulcerative Colitis. J Crohns Colitis. 2018;12:760–76.
doi: 10.1093/ecco-jcc/jjy020 pubmed: 29509882
Kawakami A, Tanaka M, Nishigaki M, Naganuma M, Iwao Y, Hibi T, Sanada H, Yamamoto-Mitani N, Kazuma K. Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: a prospective cohort study. J Gastroenterol. 2013;48:1006–15.
doi: 10.1007/s00535-012-0721-x pubmed: 23208019
Tanaka M, Iwao Y, Okamoto S, Ogata H, Hibi T, Kazuma K. Coping strategy when patients with quiescent Crohn’s disease recognize that their conditions are worsening. J Gastroenterol. 2009;44:1109–12.
doi: 10.1007/s00535-009-0104-0 pubmed: 19603135
Chan W, Chen A, Tiao D, Selinger C, Leong R. Medication adherence in inflammatory bowel disease. Intest Res. 2017;15:434–45.
doi: 10.5217/ir.2017.15.4.434 pubmed: 29142511 pmcid: 5683974
Tanaka M, Kawakami A, Iwao Y, Fukushima T, Takai Y, Yamamoto-Mitani N. The gap between Flare-Up Recognition and Judgment of need for Physician visit in patients with Ulcerative Colitis. Gastroenterol Res. 2013;6:49–55.
Conley S, Redeker N. A systematic review of self-management interventions for inflammatory bowel disease. J Nurs Scholarsh. 2016;48:118–27.
doi: 10.1111/jnu.12189 pubmed: 26756193 pmcid: 5480612
Hawthorne AB, Glatter J, Blackwell J, Ainley R, Arnott I, Barrett KJ, Bell G, Brookes MJ, Fletcher M, Muhammed R, et al. Inflammatory bowel disease patient-reported quality assessment should drive service improvement: a national survey of UK IBD units and patients. Aliment Pharmacol Ther. 2022;56:625–45.
doi: 10.1111/apt.17042 pubmed: 35770866 pmcid: 9541797
Tanaka M, Kawakami A, Sakagami K, Terai T, Fernandez J, Keefer L, Ito H. Development and validation of a Japanese version of the inflammatory bowel disease self-efficacy scale and cross-culture study in Japan and the United States. Inflamm Bowel Dis. 2023;29:1210–6.
doi: 10.1093/ibd/izac196 pubmed: 36165952
Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660–6.
doi: 10.1002/ibd.20520 pubmed: 18623174
Best WR, Becktel JM, Singleton JW, Kern F. Jr. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology. 1976;70:439–44.
doi: 10.1016/S0016-5085(76)80163-1 pubmed: 1248701
Hashimoto M, Koike T. Development of instrument to measure difficulties of life in patients with ulcerative colitis. Ochanomizu Med J. 2000;48:71–6.
de Jong MJ, Huibregtse R, Masclee AAM, Jonkers D, Pierik MJ. Patient-reported outcome measures for use in clinical trials and clinical practice in Inflammatory Bowel diseases: a systematic review. Clin Gastroenterol Hepatol. 2018;16:648–e663643.
doi: 10.1016/j.cgh.2017.10.019 pubmed: 29074448
Keefer L, Kiebles JL, Taft TH. The role of self-efficacy in inflammatory bowel disease management: preliminary validation of a disease-specific measure. Inflamm Bowel Dis. 2011;17:614–20.
doi: 10.1002/ibd.21314 pubmed: 20848516
Kawakami A, Choong LM, Tanaka M, Kunisaki R, Maeda S, Bjarnason I, Hayee B. Validation of the English version of the difficulty of life scale for patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2020;32:312–7.
doi: 10.1097/MEG.0000000000001595 pubmed: 31714389
Japanese Nursing Association. Research Report of the Japanese Nursing Association, No. 97: 2021 Hospital Nursing and Outpatient Nursing Survey Report [in Japanese]. https://www.nurse.or.jp/home/publication/pdf/research/97.pdf (2022). Accessed 11 Jan 2023.
Japan Association of Nursing Universities, Japan Association of Graduate Schools of NP Education. Written request regarding the establishment of a nurse practitioner (provisional name) system [in Japanese; a submission to the Minister of Health, Labour and Welfare]. https://www.nurse.or.jp/up_pdf/20220726151956_f.pdf (2020). Accessed 11 Jan 2023.
Chan EA, Wong F, Cheung MY, Lam W. Patients’ perceptions of their experiences with nurse-patient communication in oncology settings: a focused ethnographic study. PLoS ONE. 2018;13:e0199183.
doi: 10.1371/journal.pone.0199183 pubmed: 29912967 pmcid: 6005521
Street RL Jr., Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ Couns. 2009;74:295–301.
doi: 10.1016/j.pec.2008.11.015 pubmed: 19150199
Roberts C, Benjamin H, Chen L, Gavigan M, Gesme DH, McCarthy P, Samuels RJ, Baile WF. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20:113–8.
doi: 10.1207/s15430154jce2002_13 pubmed: 16083376
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of life in inflammatory bowel disease: a systematic review and Meta-analyses-part II. Inflamm Bowel Dis. 2018;24:966–76.
doi: 10.1093/ibd/izy015 pubmed: 29688466
Maunder RG, Greenberg GR. Comparison of a disease activity index and patients’ self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis. 2004;10:632–6.
doi: 10.1097/00054725-200409000-00020 pubmed: 15472526
Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955:1041–8.

Auteurs

Makoto Tanaka (M)

Department of Adult Health Nursing, Graduate School of Health Care Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, 113-8510, Tokyo, Japan. tanaka.cc@tmd.ac.jp.

Aki Kawakami (A)

Department of Adult Health Nursing, Graduate School of Health Care Sciences, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, 113-8510, Tokyo, Japan.

Kayoko Sakagami (K)

Kinshukai Infusion Clinic, Grand Front Osaka Tower B 9F, 3-1 Ofuka-cho, Kita-ku, 530-0011, Osaka, Japan.

Tomoko Terai (T)

Takeda Pharmaceutical Company Limited, Japan Medical Office, 1-1 Nihonbashi-Honcho 2-Chome, Chuo- ku, 103-8338, Tokyo, Japan.

Hiroaki Ito (H)

Kinshukai Infusion Clinic, Grand Front Osaka Tower B 9F, 3-1 Ofuka-cho, Kita-ku, 530-0011, Osaka, Japan. lovemagicflute@yahoo.co.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH